116 related articles for article (PubMed ID: 26499396)
1. Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer.
Tevz G; McGrath S; Demeter R; Magrini V; Jeet V; Rockstroh A; McPherson S; Lai J; Bartonicek N; An J; Batra J; Dinger ME; Lehman ML; Williams ED; Nelson CC
Mol Cell Endocrinol; 2016 Jan; 420():159-68. PubMed ID: 26499396
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and TCDD influence RLN2 gene activity in estrogen receptor-positive human breast cancer cells.
Kietz S; Feng S; Agoulnik A; Hombach-Klonisch S
Ann N Y Acad Sci; 2009 Apr; 1160():367-73. PubMed ID: 19416221
[TBL] [Abstract][Full Text] [Related]
3. Relaxin promotes prostate cancer progression.
Feng S; Agoulnik IU; Bogatcheva NV; Kamat AA; Kwabi-Addo B; Li R; Ayala G; Ittmann MM; Agoulnik AI
Clin Cancer Res; 2007 Mar; 13(6):1695-702. PubMed ID: 17363522
[TBL] [Abstract][Full Text] [Related]
4. Relaxin 2 is functional at the ocular surface and promotes corneal wound healing.
Hampel U; Klonisch T; Makrantonaki E; Sel S; Schulze U; Garreis F; Seltmann H; Zouboulis CC; Paulsen FP
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7780-90. PubMed ID: 23111608
[TBL] [Abstract][Full Text] [Related]
5. Dual blockade of PKA and NF-κB inhibits H2 relaxin-mediated castrate-resistant growth of prostate cancer sublines and induces apoptosis.
Vinall RL; Mahaffey CM; Davis RR; Luo Z; Gandour-Edwards R; Ghosh PM; Tepper CG; de Vere White RW
Horm Cancer; 2011 Aug; 2(4):224-38. PubMed ID: 21789713
[TBL] [Abstract][Full Text] [Related]
6. Evolution of the relaxin/insulin-like gene family in anthropoid primates.
Arroyo JI; Hoffmann FG; Opazo JC
Genome Biol Evol; 2014 Mar; 6(3):491-9. PubMed ID: 24493383
[TBL] [Abstract][Full Text] [Related]
7. Relaxin enhances the collagenolytic activity and in vitro invasiveness by upregulating matrix metalloproteinases in human thyroid carcinoma cells.
Bialek J; Kunanuvat U; Hombach-Klonisch S; Spens A; Stetefeld J; Sunley K; Lippert D; Wilkins JA; Hoang-Vu C; Klonisch T
Mol Cancer Res; 2011 Jun; 9(6):673-87. PubMed ID: 21493587
[TBL] [Abstract][Full Text] [Related]
8. Heterozygous deletion at the RLN1 locus in a family with testicular germ cell cancer identified by integrating copy number variation data with phenome and interactome information.
Edsgärd D; Scheel M; Hansen NT; Ralfkiaer U; Jensen TS; Skakkebaek NE; Brunak S; Gupta R; Rajpert-De Meyts E; Ottesen AM
Int J Androl; 2011 Aug; 34(4 Pt 2):e122-32. PubMed ID: 21696394
[TBL] [Abstract][Full Text] [Related]
9. Regulation of mRNA gene expression of members of the NF-κB transcription factor gene family by angiotensin II and relaxin 2 in normal and cancer prostate cell lines.
Domińska K; Kowalska K; Matysiak ZE; Płuciennik E; Ochędalski T; Piastowska-Ciesielska AW
Mol Med Rep; 2017 Jun; 15(6):4352-4359. PubMed ID: 28487955
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of upregulated H2 relaxin mRNA expression during neuroendocrine differentiation of LNCaP prostate cancer cells and production of biologically active mammalian recombinant 6 histidine-tagged H2 relaxin.
Figueiredo KA; Palmer JB; Mui AL; Nelson CC; Cox ME
Ann N Y Acad Sci; 2005 May; 1041():320-7. PubMed ID: 15956728
[TBL] [Abstract][Full Text] [Related]
11. Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancer.
Thompson VC; Hurtado-Coll A; Turbin D; Fazli L; Lehman ML; Gleave ME; Nelson CC
Prostate; 2010 Jul; 70(10):1134-45. PubMed ID: 20503398
[TBL] [Abstract][Full Text] [Related]
12. Progressive erosion of the Relaxin1 gene in bovids.
Malone L; Opazo JC; Ryan PL; Hoffmann FG
Gen Comp Endocrinol; 2017 Oct; 252():12-17. PubMed ID: 28733228
[TBL] [Abstract][Full Text] [Related]
13. A common effect of angiotensin II and relaxin 2 on the PNT1A normal prostate epithelial cell line.
Domińska K; Ochędalski T; Kowalska K; Matysiak-Burzyńska ZE; Płuciennik E; Piastowska-Ciesielska AW
J Physiol Biochem; 2016 Sep; 72(3):381-92. PubMed ID: 27119161
[TBL] [Abstract][Full Text] [Related]
14. Identification and Quantification of Human Relaxin Proteins by Immunoaffinity-Mass Spectrometry.
Rais Y; Drabovich AP
J Proteome Res; 2024 May; ():. PubMed ID: 38739617
[TBL] [Abstract][Full Text] [Related]
15. Relaxin enhances the oncogenic potential of human thyroid carcinoma cells.
Hombach-Klonisch S; Bialek J; Trojanowicz B; Weber E; Holzhausen HJ; Silvertown JD; Summerlee AJ; Dralle H; Hoang-Vu C; Klonisch T
Am J Pathol; 2006 Aug; 169(2):617-32. PubMed ID: 16877360
[TBL] [Abstract][Full Text] [Related]
16. Gene turnover and differential retention in the relaxin/insulin-like gene family in primates.
Arroyo JI; Hoffmann FG; Opazo JC
Mol Phylogenet Evol; 2012 Jun; 63(3):768-76. PubMed ID: 22405815
[TBL] [Abstract][Full Text] [Related]
17. Regulation of receptor signaling by relaxin A chain motifs: derivation of pan-specific and LGR7-specific human relaxin analogs.
Park JI; Semyonov J; Yi W; Chang CL; Hsu SY
J Biol Chem; 2008 Nov; 283(46):32099-109. PubMed ID: 18772127
[TBL] [Abstract][Full Text] [Related]
18. Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens.
Thompson VC; Morris TG; Cochrane DR; Cavanagh J; Wafa LA; Hamilton T; Wang S; Fazli L; Gleave ME; Nelson CC
Prostate; 2006 Dec; 66(16):1698-709. PubMed ID: 16998820
[TBL] [Abstract][Full Text] [Related]
19. The effects of relaxin and estrogen deficiency on collagen deposition and hypertrophy of nonreproductive organs.
Lekgabe ED; Royce SG; Hewitson TD; Tang ML; Zhao C; Moore XL; Tregear GW; Bathgate RA; Du XJ; Samuel CS
Endocrinology; 2006 Dec; 147(12):5575-83. PubMed ID: 16935837
[TBL] [Abstract][Full Text] [Related]
20. Relaxin 2/RXFP1 Signaling Induces Cell Invasion via the β-Catenin Pathway in Endometrial Cancer.
Fue M; Miki Y; Takagi K; Hashimoto C; Yaegashi N; Suzuki T; Ito K
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
